On October 26, people living with ALS, family members, friends, caregivers, and others affected by ALS will gather at Bannworth Park Pavilion for the 2024 Walk to Defeat ALS Rio Grande Valley. ALS, often called Lou Gehrig’s disease, is a progressive neurodegenerative disease affecting nerve cells in the brain and spinal cord. It gradually robs people of the ability to walk, move, talk, swallow, and eventually breathe. ALS has no known cause or cure, and the community is coming together to make ALS livable for everyone, everywhere.
Hundreds of people will rally together at Walk to Defeat ALS® to fuel the mission and support people living with ALS in the region. Many who participate have a loved one who is battling ALS while others walk in memory of a loved one who has lost their fight. Some participate simply because they believe in the power of community and want to make a difference for those impacted by ALS.
“Our Walk to Defeat ALS events bring the ALS community together, providing hope and inspiration for those impacted by ALS. Thanks to your generosity and support, we can fund global research, nationwide advocacy efforts, and local care services. All of these efforts are critical to making ALS livable until we can find a cure.” said Calaneet Balas, president and CEO of the ALS Association.
With only two to five years to live, individuals living with ALS have an urgent need, and the community is stepping in to fill it by participating for those who cannot. Walk to Defeat ALS® is the ALS Association’s signature event and funds directly support innovative research, care services, and advocacy efforts.
Bannworth Park is located at 1822 N. Shary Rd. in Mission. Walk check-in starts at 9 a.m. with the walk starting at 10:30 a.m.
Walk to Defeat ALS is the #1 way to unite and support people affected by ALS in your community. For an event near you or to register, visit www.als.org/WalkRioGrandeValley. Registered participants who raise $100 or more receive a commemorative t-shirt.
About the ALS Association
The ALS Association is the largest philanthropic funder of ALS research in the world. The Association funds global research collaborations, assists people with ALS and their families through its nationwide network of care and certified clinical care centers, and advocates for better public policies for people with ALS. The ALS Association is working to make ALS a livable disease while urgently searching for new treatments and a cure. For more information about the ALS Association, visit the website at als.org.
About ALS
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord. Throughout the disease, people lose the ability to move, speak, and eventually, to breathe. On average, it takes about a year before a final ALS diagnosis is made. The disease is always fatal, usually within five years of diagnosis. There is currently no cure.
